GlaucomaCME
LECTURECME

The LiGHT Trial: Should SLT Be the Preferred First-line Treatment?

Author(s)/Faculty: Valerie Trubnik, MD, FACS
Release Date: 4/20/2020Expiration Date: 4/19/2021
Credit Type: CMENumber of Credits: 0.25
Content Type: LectureProvider:
This educational activity will discuss the LiGHT trial and selective laser trabeculoplasty (SLT) in treating patients with glaucoma.